Despite the contact lens product maker's announcement late Wednesday that it will repurchase debt, shares slipped another 6% on Thursday after plunging Wednesday. The Wall Street Journal reported Thursday that a handful of cases of Fusarium keratitis eye infections of users of Bausch & Lomb's ReNu contact lens solution in Europe have been confirmed. Shares of Bausch & Lomb have fallen 28% since the company first announced on April 10 that it halted shipments of their ReNu with MoistureLoc...